NSIT: Novel sequence identification tool. Pupacdi, B., Javed, A., Zaki, M. J., &Ruchirawat, M. (2014). PLoS ONE, 9(9).

28 Dec 2014
0
0

NSIT: Novel sequence identification tool.
Pupacdi, B., Javed, A., Zaki, M. J., &Ruchirawat, M. (2014).
PLoS ONE, 9(9).

Tags

Share this

Related Posts

Comparative proteomic analysis of oral squamous cell carcinoma and adjacent non-tumour tissue from Thailand. Chanthammachat P, Promwikorn W, Pruegsanusak K, Roytrakul S, Srisomsap C, Chokchaichamnankit D, Svasti J, Boonyaphiphat P, K S, Thongsuksai P*. Arch Oral Biol. 2013 Nov;58(11):1677-85.
01 Nov 2013
0

Comparative proteomic analysis of oral squamous cell carcinoma and adjacent non-tumour tissue from Thailand. Chanthammachat P, Promwikorn W, Pruegsanusak K, Roytrakul S, Srisomsap C, Chokchaichamnankit D, Svasti J, Boonyaphiphat P, K S, Thongsuksai P*. Arch Oral Biol. 2013 Nov;58(11):1677-85.

Comparative proteomic analysis of oral squamous cell carcinoma and adjacent non-tumour tissue from Thailand. Chanthammachat P, Promwikorn W, Pruegsanusak K, Roytrakul S, Srisomsap C, Chokchaichamnankit D, Svasti J, Boonyaphiphat P, K S, Thongsuksai P*. Arch Oral Biol. 2013 Nov;58(11):1677-85.
View More

Recent Posts

Efficacy of Andrographis paniculata extract treatment in mild to moderate COVID-19 patients being treated with favipiravir: A double-blind, randomized, placebo-controlled study (APFaVi trial)
20 Sep 2023
0

Efficacy of Andrographis paniculata extract treatment in mild to moderate COVID-19 patients being treated with favipiravir: A double-blind, randomized, placebo-controlled study (APFaVi trial)

Efficacy of Andrographis paniculata extract treatment in mild to moderate COVID-19 patients being treated with favipiravir: A double-blind, randomized, placebo-controlled study (APFaVi trial) Siripongboonsitti T, Ungtrakul T, Tawinprai K, Auewarakul C, Chartisathian W, Jansala T, Julsawad R, Soonklang K, Mahanonda N, Mahidol C Phytomedicine. 2023;119:155018.
View More